Schedule 13D ownership disclosure

CESCA THERAPEUTICS INC.

Security class unavailable · CUSIP: 157131103

Event date: 2016-12-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,367,647
Percent of class
69.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-18-007986
Form type
SC 13D
Filer
Boyalife Asset Holding II, Inc.
CIK
CIK 1738415
Filed
Apr 27, 2018
Reporting period
Dec 26, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub